ACCES VITAL TECHNOLOGY : revenue, balance sheet and financial ratios

ACCES VITAL TECHNOLOGY is a French company founded 26 years ago, specialized in the sector Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logiciels. Based in AUBAGNE (13400), this company of category PME shows in 2023 a revenue of 15.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ACCES VITAL TECHNOLOGY (SIREN 424489219)
Indicator 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 15 438 509 € 16 108 302 € 16 644 294 € 13 964 403 € 15 568 416 € 14 796 019 € 13 560 277 € 12 621 744 € 12 223 346 €
Net income 1 131 380 € 1 260 200 € 1 379 843 € 1 112 080 € 887 087 € 993 143 € 718 389 € 615 682 € 681 232 €
EBITDA 1 585 329 € 1 720 101 € 1 916 022 € 1 582 857 € 1 296 842 € 1 468 271 € 1 065 255 € 931 198 € 1 039 156 €
Net margin 7.3% 7.8% 8.3% 8.0% 5.7% 6.7% 5.3% 4.9% 5.6%

Revenue and income statement

In 2023, ACCES VITAL TECHNOLOGY achieves revenue of 15.4 M€. Revenue is growing positively over 9 years (CAGR: +3.0%). Slight decline of -4% vs 2022. After deducting consumption (12.2 M€), gross margin stands at 3.2 M€, i.e. a rate of 21%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.6 M€, representing 10.3% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.1 M€, i.e. 7.3% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2023) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

15 438 509 €

Gross margin (2023) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

3 202 528 €

EBITDA (2023) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

1 585 329 €

EBIT (2023) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

1 560 408 €

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

1 131 380 €

EBITDA margin (2023) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

10.3%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 25%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.4 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 7.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

24.622%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

62.81%

Cash flow / Revenue (2023) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

7.487%

Repayment capacity (2023) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

1.35

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

26.1%

Solvency indicators evolution
ACCES VITAL TECHNOLOGY

Sector positioning

Debt ratio
24.62 2023
2021
2022
2023
Q1: 0.03
Med: 11.33
Q3: 52.83
Average +20 pts over 3 years

In 2023, the debt ratio of ACCES VITAL TECHNOLOGY (24.62) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
62.81% 2023
2021
2022
2023
Q1: 13.23%
Med: 35.49%
Q3: 56.03%
Excellent

In 2023, the financial autonomy of ACCES VITAL TECHNOLOGY (62.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
1.35 years 2023
2021
2022
2023
Q1: 0.0 years
Med: 0.03 years
Q3: 1.66 years
Average +16 pts over 3 years

In 2023, the repayment capacity of ACCES VITAL TECHNOLOGY (1.35) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 454.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 3.3x. Financial charges are adequately covered by operations.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

454.693

Interest coverage (2023) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

3.274

Liquidity indicators evolution
ACCES VITAL TECHNOLOGY

Sector positioning

Liquidity ratio
454.69 2023
2021
2022
2023
Q1: 146.39
Med: 218.61
Q3: 366.27
Excellent +14 pts over 3 years

In 2023, the liquidity ratio of ACCES VITAL TECHNOLOGY (454.69) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
3.27x 2023
2021
2022
2023
Q1: 0.0x
Med: 0.08x
Q3: 4.0x
Good +19 pts over 3 years

In 2023, the interest coverage of ACCES VITAL TECHNOLOGY (3.3x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 29 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 55 days. Favorable situation: supplier credit is longer than customer credit by 26 days. Inventory turnover is 32 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 64 days of revenue, i.e. 2.8 M€ to permanently finance.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

2 751 760 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

29 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

55 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

32 j

WCR in days of revenue (2023) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

64 j

WCR and payment terms evolution
ACCES VITAL TECHNOLOGY

Positioning of ACCES VITAL TECHNOLOGY in its sector

Comparison with sector Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logiciels

Valuation estimate

Based on 61 transactions of similar company sales (all years), the value of ACCES VITAL TECHNOLOGY is estimated at 4 298 085 € (range 1 070 107€ - 7 850 387€). With an EBITDA of 1 585 329€, the sector multiple of 2.5x is applied. The price/revenue ratio is 0.33x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2023
61 tx
1070k€ 4298k€ 7850k€
4 298 085 € Range: 1 070 107€ - 7 850 387€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
1 585 329 € × 2.5x
Estimation 3 962 575 €
867 021€ - 8 048 359€
Revenue Multiple 30%
15 438 509 € × 0.33x
Estimation 5 071 488 €
1 479 161€ - 6 727 906€
Net Income Multiple 20%
1 131 380 € × 3.5x
Estimation 3 976 757 €
964 244€ - 9 039 181€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 61 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logiciels)

Compare ACCES VITAL TECHNOLOGY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logiciels

Frequently asked questions about ACCES VITAL TECHNOLOGY

What is the revenue of ACCES VITAL TECHNOLOGY ?

The revenue of ACCES VITAL TECHNOLOGY in 2023 is 15.4 M€.

Is ACCES VITAL TECHNOLOGY profitable?

Yes, ACCES VITAL TECHNOLOGY generated a net profit of 1.1 M€ in 2023.

Where is the headquarters of ACCES VITAL TECHNOLOGY ?

The headquarters of ACCES VITAL TECHNOLOGY is located in AUBAGNE (13400), in the department Bouches-du-Rhone.

Where to find the tax return of ACCES VITAL TECHNOLOGY ?

The tax return of ACCES VITAL TECHNOLOGY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ACCES VITAL TECHNOLOGY operate?

ACCES VITAL TECHNOLOGY operates in the sector Commerce de gros (commerce interentreprises) d'ordinateurs, d'équipements informatiques périphériques et de logiciels (NAF code 46.51Z). See the 'Sector positioning' section above to compare the company with its competitors.